Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: A cross-sectional study

  1. Estébanez, M.
  2. Stella-Ascariz, N.
  3. Mingorance, J.
  4. Pérez-Valero, I.
  5. Bernardino, J.I.
  6. Zamora, F.X.
  7. Montes, M.L.
  8. González-García, J.J.
  9. Arribas, J.R.
Aldizkaria:
BMC Infectious Diseases

ISSN: 1471-2334

Argitalpen urtea: 2014

Alea: 14

Zenbakia: 1

Mota: Artikulua

DOI: 10.1186/1471-2334-14-379 GOOGLE SCHOLAR lock_openSarbide irekia editor